Page last updated: 2024-10-25

amphetamine and Agoraphobia

amphetamine has been researched along with Agoraphobia in 2 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Agoraphobia: Obsessive, persistent, intense fear of open places.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Djenderedjian, A1
Tashjian, R1
Louie, AK1
Lannon, RA1
Ketter, TA1

Other Studies

2 other studies available for amphetamine and Agoraphobia

ArticleYear
Agoraphobia following amphetamine withdrawal.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:6

    Topics: Adult; Agoraphobia; Amphetamine; Female; Humans; Obesity; Phobic Disorders; Substance Withdrawal Syn

1982
Treatment of cocaine-induced panic disorder.
    The American journal of psychiatry, 1989, Volume: 146, Issue:1

    Topics: Adult; Agoraphobia; Amphetamine; Cocaine; Fear; Female; Humans; Male; Panic; Risk Factors; Substance

1989